U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07881172) titled 'Prospective Multicenter Study of the Genomic, Transcriptomic, and Biological Profile of Patients With Neuroblastoma' on Oct. 12.
Brief Summary: This is an investigator-initiated, multicenter, prospective, non-profit study.
Patients who provide informed consent to participate will be asked to provide a peripheral blood sample, a fresh tumor tissue sample (obtained by biopsy), and/or a bone marrow sample.
All patients with neuroblastoma at diagnosis, with relapsed disease, or with refractory disease may participate, provided that the diagnosis and disease status are established by the treating physician in accordance with national c...